Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

A somatic TSHR mutation in a patient with lung adenocarcinoma with bronchioloalveolar carcinoma, coronary artery disease and severe chronic obstructive pulmonary disease.

Kim JW, Lee S, Lui N, Choi H, Mulvihill M, Fang LT, Kang HC, Kwon YW, Jablons D, Kim IJ.

Oncol Rep. 2012 Oct;28(4):1225-30. doi: 10.3892/or.2012.1938. Epub 2012 Jul 26.

PMID:
22842620
2.

Lipase member H is a novel secreted protein selectively upregulated in human lung adenocarcinomas and bronchioloalveolar carcinomas.

Seki Y, Yoshida Y, Ishimine H, Shinozaki-Ushiku A, Ito Y, Sumitomo K, Nakajima J, Fukayama M, Michiue T, Asashima M, Kurisaki A.

Biochem Biophys Res Commun. 2014 Jan 24;443(4):1141-7. doi: 10.1016/j.bbrc.2013.12.106. Epub 2013 Dec 28.

PMID:
24380866
3.

Glypican-3 is overexpressed in lung squamous cell carcinoma, but not in adenocarcinoma.

Aviel-Ronen S, Lau SK, Pintilie M, Lau D, Liu N, Tsao MS, Jothy S.

Mod Pathol. 2008 Jul;21(7):817-25. doi: 10.1038/modpathol.2008.37. Epub 2008 May 9.

4.

Molecular characterization of chronic obstructive pulmonary disease-related non-small cell lung cancer through aberrant methylation and alterations of EGFR signaling.

Suzuki M, Wada H, Yoshino M, Tian L, Shigematsu H, Suzuki H, Alaa M, Tamura H, Fujiwara T, Nagato K, Motohashi S, Moriya Y, Hoshino H, Yoshida S, Shibuya K, Hiroshima K, Nakatani Y, Yoshino I.

Ann Surg Oncol. 2010 Mar;17(3):878-88. doi: 10.1245/s10434-009-0739-3. Epub 2009 Oct 16.

PMID:
19841986
5.

Clinicopathological and molecular evidence indicating the independence of bronchioloalveolar components from other subtypes of human peripheral lung adenocarcinoma.

Koga T, Hashimoto S, Sugio K, Yoshino I, Mojtahedzadeh S, Matsuo Y, Yonemitsu Y, Sugimachi K, Sueishi K.

Clin Cancer Res. 2001 Jun;7(6):1730-8.

6.

Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic disease.

Mackinnon AC, Tretiakova M, Henderson L, Mehta RG, Yan BC, Joseph L, Krausz T, Husain AN, Reid ME, Salgia R.

J Clin Pathol. 2011 Jan;64(1):16-24. doi: 10.1136/jcp.2010.075853. Epub 2010 Nov 2.

7.

Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung.

Yoshida Y, Shibata T, Kokubu A, Tsuta K, Matsuno Y, Kanai Y, Asamura H, Tsuchiya R, Hirohashi S.

Lung Cancer. 2005 Oct;50(1):1-8.

PMID:
15950315
8.

Global gene expression differentiating pure bronchioloalveolar carcinoma from adenocarcinoma with bronchioloalveolar carcinoma features.

Zhang WC, Zhang ZF, You J, Wang CL.

Eur J Cardiothorac Surg. 2013 Apr;43(4):765-71. doi: 10.1093/ejcts/ezs427. Epub 2012 Aug 3.

PMID:
22864788
9.

SCCRO expression correlates with invasive progression in bronchioloalveolar carcinoma.

Sarkaria IS, Pham D, Ghossein RA, Talbot SG, Hezel M, Dudas ME, Ebright MI, Chuai S, Memoli N, Venkatraman ES, Miller VA, Kris MG, Zakowski MF, Rusch VW, Singh B.

Ann Thorac Surg. 2004 Nov;78(5):1734-41. Review.

PMID:
15511464
10.

Expression profiling of integrins in lung cancer cells.

Guo L, Zhang F, Cai Y, Liu T.

Pathol Res Pract. 2009;205(12):847-53. doi: 10.1016/j.prp.2009.07.005. Epub 2009 Aug 11.

PMID:
19674850
11.

A correlation between EGFR gene mutation status and bronchioloalveolar carcinoma features in Japanese patients with adenocarcinoma.

Haneda H, Sasaki H, Lindeman N, Kawano O, Endo K, Suzuki E, Shimizu S, Yukiue H, Kobayashi Y, Yano M, Fujii Y.

Jpn J Clin Oncol. 2006 Feb;36(2):69-75. Epub 2006 Jan 31.

PMID:
16449241
13.

Heterogeneity of epidermal growth factor receptor mutations within a mixed adenocarcinoma lung nodule.

Nakano H, Soda H, Takasu M, Tomonaga N, Yamaguchi H, Nakatomi K, Fujino S, Hayashi T, Nakamura Y, Tsukamoto K, Kohno S.

Lung Cancer. 2008 Apr;60(1):136-40. Epub 2007 Sep 24.

PMID:
17889960
14.

Clinicopathological features of lung adenocarcinoma with KRAS mutations.

Kakegawa S, Shimizu K, Sugano M, Miyamae Y, Kaira K, Araki T, Nakano T, Kamiyoshihara M, Kawashima O, Takeyoshi I.

Cancer. 2011 Sep 15;117(18):4257-66. doi: 10.1002/cncr.26010. Epub 2011 Mar 8.

15.

Expression and correlation of sodium/iodide symporter and thyroid stimulating hormone receptor in human thyroid carcinoma.

Wang ZF, Liu QJ, Liao SQ, Yang R, Ge T, He X, Tian CP, Liu W.

Tumori. 2011 Jul-Aug;97(4):540-6. doi: 10.1700/950.10410.

16.

OCT4 expression in human non-small cell lung cancer: implications for therapeutic intervention.

Karoubi G, Gugger M, Schmid R, Dutly A.

Interact Cardiovasc Thorac Surg. 2009 Apr;8(4):393-7. doi: 10.1510/icvts.2008.193995. Epub 2009 Jan 5.

PMID:
19126554
17.

Genetic evolution of epidermal growth factor receptor in adenocarcinoma with a bronchioloalveolar carcinoma component.

Zhong WZ, Wu YL, Yang XN, Guo AL, Su J, Zhang XC, Luo DL, Wang Z, Chen HJ, Zhou Q, Xu CR, Qiao GB, Liao RQ, Yang JJ, Mok TS.

Clin Lung Cancer. 2010 May;11(3):160-8. doi: 10.3816/CLC.2010.n.020.

PMID:
20439191
18.

Stat3 downstream genes serve as biomarkers in human lung carcinomas and chronic obstructive pulmonary disease.

Qu P, Roberts J, Li Y, Albrecht M, Cummings OW, Eble JN, Du H, Yan C.

Lung Cancer. 2009 Mar;63(3):341-7. doi: 10.1016/j.lungcan.2008.05.025. Epub 2008 Jul 9.

19.

Somatic alterations of the serine/threonine kinase LKB1 gene in squamous cell (SCC) and large cell (LCC) lung carcinoma.

Strazisar M, Mlakar V, Rott T, Glavac D.

Cancer Invest. 2009 May;27(4):407-16. doi: 10.1080/07357900802427919.

PMID:
19229701
20.

Supplemental Content

Support Center